Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

by Alex Brown Contributor

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   503    Comments 0
Topics:

BOC Sciences successfully participated in TIDES USA 2022 from May 9th to 12th, at Hynes Convention Center, Boston. During the four-day exhibition, experts from BOC Sciences and global visitors are engaged in heated discussions concerning novel advances in peptide and amino acid synthesis, discovery, design, and engineering.

BOC Sciences has been preparing for the world's largest gathering of pharmaceutical industry for several months. This year, it attracts a great number of researchers who are interested in accelerating oligonucleotide, peptide, mRNA, and genome editing products from early discovery to late-stage development and commercialization. BOC Sciences expects to take this opportunity and showcase its cutting-edge technologies in manufacturing peptide and amino acid products on the global stage.

Its attendance at TIDES USA 2022 turns out to be a great success since plenty of guests including some influential researchers paid a visit to its booth and had an in-depth conversation with its representatives. "It's really beyond our expectation that many researchers show interest in our peptide products," the business development manager who is also one of the representatives from BOC Sciences told reporters.

BOC Sciences has accumulated years of experience in peptide production and prides itself on varieties of peptide options offered to customers. A major type of its star products exhibited at TIDES USA 2022 is antimicrobial peptides (AMPs), which display a broad range of inhibitory effects against bacteria, fungi, parasites, and viruses. Owing to the increasing concerns about the abuse of antibiotics and the emergence of antibiotic-resistant microorganisms, academia and pharmaceutical companies as well as many biochemical suppliers like BOC Sciences have invested much energy in AMP development.

AMPs can be obtained from different sources. Some of them directly come from nature while others should go through complex synthetic processes. As the specialist in peptide manufacturing, BOC Sciences now owns mature techniques and advanced equipment to yield the vast majority of AMPs, which are either naturally obtained such as indolicidin, or custom synthesized such as omiganan pentahydrochloride.

BOC Sciences is now continuously researching AMPs and storing considerable data in its peptide database. However, the mechanism of AMPs is still not fully explored and further work needs to be done to obtain cost-effective AMPs with extraordinary immunomodulatory effects and high specificity.

TIDES USA 2022 is not a lonely step taken by BOC Sciences to exhibit its expertise in peptide provision. It is now considering wider engagement in global pharma exhibitions and academic conferences. For more information about the rising biochemical supplier, please visit https://aapep.bocsci.com/.

About

BOC Sciences is a leading biochemical manufacturer and supplier with over 12,000 amino acids, peptides, and resins serving both scientific and commercial needs.

Subscribe to Newsletter
Share this:              

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *